2009
DOI: 10.1590/s1806-37132009000700014
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: : [713][714][715][716] and adverse effects are observed in more than half of the patients treated with this drug. However, pulmonary-related adverse effects are uncommon. Ribavirin is another antiviral drug, typically used in combination with interferon, and there have been no reports of respiratory-related side effects in patients treated with ribavirin as monotherapy. (3,4) To date, there have been no reports of interferon or ribavirin being associated with bronchial casts. Here, we report the case of a pati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
references
References 7 publications
0
0
0
Order By: Relevance